<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Methods_To_Handle_Fludarabine_Before_Time_Runs_Out</id>
		<title>Methods To Handle Fludarabine Before Time Runs Out - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Methods_To_Handle_Fludarabine_Before_Time_Runs_Out"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Methods_To_Handle_Fludarabine_Before_Time_Runs_Out&amp;action=history"/>
		<updated>2026-06-13T11:26:33Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Methods_To_Handle_Fludarabine_Before_Time_Runs_Out&amp;diff=151850&amp;oldid=prev</id>
		<title>Animal13neck: Створена сторінка: The prevalence of hepatitis B among M��ori patients (56%; 95% CI 45%-67%) was more than double that of non-M��ori (27%; 95% CI 19%-36%). The hazard rati...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Methods_To_Handle_Fludarabine_Before_Time_Runs_Out&amp;diff=151850&amp;oldid=prev"/>
				<updated>2017-03-13T18:55:30Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: The prevalence of hepatitis B among M��ori patients (56%; 95% CI 45%-67%) was more than double that of non-M��ori (27%; 95% CI 19%-36%). The hazard rati...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;The prevalence of hepatitis B among M��ori patients (56%; 95% CI 45%-67%) was more than double that of non-M��ori (27%; 95% CI 19%-36%). The hazard ratio [http://www.selleckchem.com Fludarabine] for cancer-specific death for M��ori compared with non-M��ori was 1.36 (95% CI 0.96�C1.92). Conclusions and implications: HCC remains an important health problem particularly for M��ori men. Efforts to improve coverage of screening for hepatitis B and surveillance of those with chronic hepatitis should be a priority to address the large inequalities found in liver cancer epidemiology. &amp;quot;&amp;quot;Objectives: We assessed the independent contribution of C-reactive protein to the risk of cardiovascular disease in Aboriginal Australians. Methods: High sensitivity CRP levels were measured in 705 Aboriginal participants aged 20�C74 years free from CVD at baseline. Participants were followed for a median of 11 years. Cox proportional hazards models were used to assess the association of CRP with the risk of developing CVD events.  Results: A total of 114 participants were diagnosed with CVD. Incidence rates were 5.4 and 21.4 per 1,000 person-years for the lower (&lt;/div&gt;</summary>
		<author><name>Animal13neck</name></author>	</entry>

	</feed>